Papers

1

Total Citations

5

H-Index

1

About

Dr. Jingwen Hu is a leading researcher in urologic oncology, with a primary focus on surgical outcomes for bladder cancer. Her work centers on comparative effectiveness research, employing advanced statistical methods to evaluate long-term oncologic results across different surgical approaches. Dr. Hu’s major contribution lies in her application of Bayesian network meta-analysis to compare open, laparoscopic, and robot-assisted radical cystectomy, providing nuanced insights into their relative benefits and risks. Her most-cited paper, published in 2022, synthesizes data from multiple studies to clarify survival and recurrence outcomes, offering critical guidance for surgical decision-making. With 5 citations to date, this work has already influenced clinical discussions in the field. Dr. Hu’s research is notable for its methodological rigor, moving beyond traditional pairwise comparisons to deliver a more comprehensive evidence base. Her efforts are helping to shape best practices in bladder cancer surgery, making her a valuable voice in the ongoing debate over minimally invasive versus open techniques.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Bayesian network analysis of long-term oncologic outcomes of open, laparoscopic, and robot-assisted radical cystectomy for bladder cancer
5 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Chengdu University of Traditional Chinese Medicine

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago